{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:27:54Z","timestamp":1790868474756,"version":"4.1.0"},"reference-count":24,"publisher":"American Association for Cancer Research (AACR)","issue":"3","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Analysis of gene expression data suggests that breast cancers are divisible into molecular subtypes which have distinct clinical features. This study evaluates whether pathologic features and etiologic associations differ among molecular subtypes. We evaluated 804 women with invasive breast cancers and 2,502 controls participating in a Polish Breast Cancer Study. Immunohistochemical stains for estrogen receptor \u03b1, progesterone receptor, human epidermal growth factor receptors (HER2 and HER1), and cytokeratin 5 were used to classify cases into five molecular subtypes: luminal A, luminal B, HER2-expresing, basal-like, and unclassified. Relative risks were estimated using adjusted odds ratios and 95% confidence intervals. We observed that compared with the predominant luminal A tumors (69%), other subtypes were associated with unfavorable clinical features at diagnosis, especially HER2-expressing (8%) and basal-like (12%) tumors. Increasing body mass index significantly reduced the risk of luminal A tumors among premenopausal women (odds ratios, 0.71; 95% confidence intervals, 0.57-0.88 per five-unit increase), whereas it did not reduce risk for basal-like tumors (1.18; 0.86-1.64; Pheterogeneity = 0.003). On the other hand, reduced risk associated with increasing age at menarche was stronger for basal-like (0.78; 0.68-0.89 per 2-year increase) than luminal A tumors (0.90; 0.95-1.08; Pheterogeneity = 0.0009). Although family history increased risk for all subtypes (except for unclassified tumors), the magnitude of the relative risk was highest for basal-like tumors. Results from this study have shown that breast cancer risk factors may vary by molecular subtypes identified in expression studies, suggesting etiologic, in addition to clinical, heterogeneity of breast cancer. (Cancer Epidemiol Biomarkers Prev 2007;16(3):439\u201343)<\/jats:p>","DOI":"10.1158\/1055-9965.epi-06-0806","type":"journal-article","created":{"date-parts":[[2007,3,19]],"date-time":"2007-03-19T21:00:04Z","timestamp":1174338004000},"page":"439-443","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":356,"title":["Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study"],"prefix":"10.1158","volume":"16","author":[{"given":"Xiaohong R.","family":"Yang","sequence":"first","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Sherman","sequence":"additional","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Rimm","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Yale University School of Medicine, New Haven, Connecticut;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Lissowska","sequence":"additional","affiliation":[{"name":"4Department of Cancer Epidemiology and Prevention, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise A.","family":"Brinton","sequence":"additional","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Peplonska","sequence":"additional","affiliation":[{"name":"6Department of Occupational andEnvironmental Epidemiology, Nofer Institute of Occupational Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Hewitt","sequence":"additional","affiliation":[{"name":"2Tissue Array Research Program, Laboratory of Pathology, Center For Cancer Research, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Anderson","sequence":"additional","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neonila","family":"Szeszenia-Da\u0328browska","sequence":"additional","affiliation":[{"name":"6Department of Occupational andEnvironmental Epidemiology, Nofer Institute of Occupational Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Bardin-Mikolajczak","sequence":"additional","affiliation":[{"name":"4Department of Cancer Epidemiology and Prevention, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witold","family":"Zatonski","sequence":"additional","affiliation":[{"name":"4Department of Cancer Epidemiology and Prevention, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cartun","sequence":"additional","affiliation":[{"name":"9Department of Pathology, Hartford Hospital, Hartford, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniza","family":"Mandich","sequence":"additional","affiliation":[{"name":"9Department of Pathology, Hartford Hospital, Hartford, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Rymkiewicz","sequence":"additional","affiliation":[{"name":"5Department of Pathology, Cancer Center and M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Ligaj","sequence":"additional","affiliation":[{"name":"5Department of Pathology, Cancer Center and M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislaw","family":"Lukaszek","sequence":"additional","affiliation":[{"name":"8Department of Clinical Pathomorphology, Polish Mother's Memorial Hospital-Research Institute, \u0141o\u0301dz\u0301, Poland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radzisaw","family":"Kordek","sequence":"additional","affiliation":[{"name":"7Department of Pathology, Medical University of \u0141o\u0301dz\u0301;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Garci\u0301a-Closas","sequence":"additional","affiliation":[{"name":"1Division of Cancer Epidemiology and Genetics,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,3,19]]},"reference":[{"key":"2022061002344005900_BIB1","doi-asserted-by":"crossref","unstructured":"Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature\u20082000;406:747\u201352.","DOI":"10.1038\/35021093"},{"key":"2022061002344005900_BIB2","doi-asserted-by":"crossref","unstructured":"Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A\u20082003;100:8418\u201323.","DOI":"10.1073\/pnas.0932692100"},{"key":"2022061002344005900_BIB3","doi-asserted-by":"crossref","unstructured":"Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res\u20082004;10:5367\u201374.","DOI":"10.1158\/1078-0432.CCR-04-0220"},{"key":"2022061002344005900_BIB4","doi-asserted-by":"crossref","unstructured":"Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA\u20082006;295:2492\u2013502.","DOI":"10.1001\/jama.295.21.2492"},{"key":"2022061002344005900_BIB5","doi-asserted-by":"crossref","unstructured":"Lacroix M, Toillon RA, Leclercq G. Stable \u2018portrait\u2019 of breast tumors during progression: data from biology, pathology and genetics. Endocr Relat Cancer\u20082004;11:497\u2013522.","DOI":"10.1677\/erc.1.00758"},{"key":"2022061002344005900_BIB6","doi-asserted-by":"crossref","unstructured":"Yasui Y, Potter JD. The shape of age-incidence curves of female breast cancer by hormone-receptor status. Cancer Causes Control\u20081999;10:431\u20137.","DOI":"10.1023\/A:1008970121595"},{"key":"2022061002344005900_BIB7","doi-asserted-by":"crossref","unstructured":"Anderson WF, Chatterjee N, Ershler WB, Brawley OW. Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat\u20082002;76:27\u201336.","DOI":"10.1023\/A:1020299707510"},{"key":"2022061002344005900_BIB8","doi-asserted-by":"crossref","unstructured":"Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev\u20082004;13:1558\u201368.","DOI":"10.1016\/S1047-2797(03)00136-4"},{"key":"2022061002344005900_BIB9","doi-asserted-by":"crossref","unstructured":"Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst\u20082004;96:218\u201328.","DOI":"10.1093\/jnci\/djh025"},{"key":"2022061002344005900_BIB10","unstructured":"Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S. Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev\u20082003;12:1053\u201360."},{"key":"2022061002344005900_BIB11","doi-asserted-by":"crossref","unstructured":"Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol\u20082000;151:703\u201314.","DOI":"10.1093\/oxfordjournals.aje.a010265"},{"key":"2022061002344005900_BIB12","doi-asserted-by":"crossref","unstructured":"Rusiecki JA, Holford TR, Zahm SH, Zheng T. Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status. Cancer Detect Prev\u20082005;29:419\u201326.","DOI":"10.1016\/j.cdp.2005.07.004"},{"key":"2022061002344005900_BIB13","doi-asserted-by":"crossref","unstructured":"Garcia-Closas M, Brinton LA, Lissowska J, et al. Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer\u20082006;95:123\u20135.","DOI":"10.1038\/sj.bjc.6603207"},{"key":"2022061002344005900_BIB14","doi-asserted-by":"crossref","unstructured":"van de RM, Perou CM, Tibshirani R, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol\u20082002;161:1991\u20136.","DOI":"10.1016\/S0002-9440(10)64476-8"},{"key":"2022061002344005900_BIB15","doi-asserted-by":"crossref","unstructured":"Menard S, Fortis S, Castiglioni F, Agresti R, Balsari A. HER2 as a prognostic factor in breast cancer. Oncology\u20082001;61:67\u201372.","DOI":"10.1159\/000055404"},{"key":"2022061002344005900_BIB16","doi-asserted-by":"crossref","unstructured":"Cleary MP, Maihle NJ. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med\u20081997;216:28\u201343.","DOI":"10.3181\/00379727-216-44153B"},{"key":"2022061002344005900_BIB17","doi-asserted-by":"crossref","unstructured":"Biro FM, Huang B, Crawford PB, et al. Pubertal correlates in black and white girls. J Pediatr\u20082006;148:234\u201340.","DOI":"10.1016\/j.jpeds.2005.10.020"},{"key":"2022061002344005900_BIB18","doi-asserted-by":"crossref","unstructured":"Demerath EW, Towne B, Chumlea WC, et al. Recent decline in age at menarche: the Fels Longitudinal Study. Am J Hum Biol\u20082004;16:453\u20137.","DOI":"10.1002\/ajhb.20039"},{"key":"2022061002344005900_BIB19","doi-asserted-by":"crossref","unstructured":"Himes JH. Examining the evidence for recent secular changes in the timing of puberty in US children in light of increases in the prevalence of obesity. Mol Cell Endocrinol\u20082006;254\u20135:13\u201321.","DOI":"10.1016\/j.mce.2006.04.013"},{"key":"2022061002344005900_BIB20","doi-asserted-by":"crossref","unstructured":"Foulkes WD, Stefansson IM, Chappuis PO, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst\u20082003;95:1482\u20135.","DOI":"10.1093\/jnci\/djg050"},{"key":"2022061002344005900_BIB21","doi-asserted-by":"crossref","unstructured":"Kotsopoulos J, Lubinski J, Lynch HT, et al. Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Causes Control\u20082005;16:667\u201374.","DOI":"10.1007\/s10552-005-1724-1"},{"key":"2022061002344005900_BIB22","doi-asserted-by":"crossref","unstructured":"Jernstrom H, Lerman C, Ghadirian P, et al. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet\u20081999;354:1846\u201350.","DOI":"10.1016\/S0140-6736(99)04336-6"},{"key":"2022061002344005900_BIB23","doi-asserted-by":"crossref","unstructured":"Kotsopoulos J, Olopado OI, Ghadirian P, et al. Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res\u20082005;7:R833\u201343.","DOI":"10.1186\/bcr1293"},{"key":"2022061002344005900_BIB24","doi-asserted-by":"crossref","unstructured":"Nkondjock A, Robidoux A, Paredes Y, Narod SA, Ghadirian P. Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians. Breast Cancer Res Treat\u20082006;98:285\u201394.","DOI":"10.1007\/s10549-006-9161-8"}],"container-title":["Cancer Epidemiology, Biomarkers &amp; Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cebp\/article-pdf\/16\/3\/439\/2266062\/439.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cebp\/article-pdf\/16\/3\/439\/2266062\/439.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T13:23:20Z","timestamp":1654867400000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cebp\/article\/16\/3\/439\/260456\/Differences-in-Risk-Factors-for-Breast-Cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,1]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2007,3,19]]},"published-print":{"date-parts":[[2007,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1055-9965.epi-06-0806","relation":{},"ISSN":["1055-9965","1538-7755"],"issn-type":[{"value":"1055-9965","type":"print"},{"value":"1538-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,1]]}}}